Namodenoson Treatment of Advanced Pancreatic Cancer

Clinical trial NCT06387342 · RECRUITING

Trial details

NCT number: NCT06387342
Sponsor: Can-Fite BioPharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Pancreatic Cancer

Start date: 2024-11-10
Primary completion: 2026-07-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.